Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3733856 | 1.00 | TLR4 (0.57) | TLR4LY96 | |
| SCHEMBL3739987 | 1.00 | TLR4 (0.57) | TLR4LY96 | |
| SCHEMBL13900939 | 0.89 | TLR4 (0.70) | TLR4LY96 | |
| SCHEMBL15197566 | 0.89 | TLR4 (0.70) | TLR4LY96 | |
| SCHEMBL13041679 | 0.89 | TLR4 (0.70) | TLR4LY96 | |
| SCHEMBL3747057 | 0.89 | TLR4 (0.70) | TLR4LY96 | |
| SCHEMBL13041682 | 0.89 | TLR4 (0.70) | TLR4LY96 | |
| SCHEMBL15197571 | 0.89 | TLR4 (0.70) | TLR4LY96 | |
| SCHEMBL3739190 | 0.89 | TLR4 (0.70) | TLR4LY96 | |
| SCHEMBL13041680 | 0.89 | TLR4 (0.70) | TLR4LY96 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1482955-B1 | PROPHYLACTIC AND THERAPEUTIC TREATMENT OF INFECTIOUS AND OTHER DISEASES WITH IMMUNOEFFECTOR COMPOUNDS | CORIXA CORP (US) | 2013-12-25 | — | — | EP | disclosed |
| US-7829542-B2 | Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds | CORIXA CORPORATION (US) | 2010-11-09 | — | — | US | disclosed |
| EP-1482795-B1 | NEW IMMUNOEFFECTOR COMPOUNDS | CORIXA CORP (US) | 2009-11-11 | — | — | EP | disclosed |
| US-20080227729-A1 | PROPHYLACTIC AND THERAPEUTIC TREATMENT OF INFECTIOUS AND OTHER DISEASES WITH IMMUNOEFFECTOR COMPOUNDS | CORIXA CORPORATION (US) | 2008-09-18 | — | — | US | disclosed |
| EP-1482955-A4 | PROPHYLACTIC AND THERAPEUTIC TREATMENT OF INFECTIOUS AND OTHER DISEASES WITH IMMUNOEFFECTOR COMPOUNDS | CORIXA CORP (US) | 2008-08-06 | — | — | EP | disclosed |
| US-20050192250-A1 | Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds | CORIXA CORPORATION (US) | 2005-09-01 | — | — | US | disclosed |
| US-6911434-B2 | Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds | CORIXA CORPORATION (US) | 2005-06-28 | — | — | US | disclosed |
| EP-1482955-A1 | PROPHYLACTIC AND THERAPEUTIC TREATMENT OF INFECTIOUS AND OTHER DISEASES WITH IMMUNOEFFECTOR COMPOUNDS | CORIXA CORPORATION (US) | 2004-12-08 | — | — | EP | disclosed |
| WO-2003066065-A1 | PROPHYLACTIC AND THERAPEUTIC TREATMENT OF INFECTIOUS AND OTHER DISEASES WITH IMMUNOEFFECTOR COMPOUNDS | CORIXA CORPORATION (US) | 2003-08-14 | — | — | WO | disclosed |
| US-20030148993-A1 | Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds | CORIXA CORPORATION | 2003-08-07 | — | — | US | disclosed |
| US-6525028-B1 | 2-deoxy-2-amino- beta -D-glucopyranose (glucosamine) glycosidically linked to a cyclic aminoalkyl (aglycon) group; presence or absence of an antigen | CORIXA CORPORATION | 2003-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050192250-A1 | Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds | NFATC1, AGPS, HLA-DRB1 | TLR4 119/4885LY96 113/4885 |
| US-20080227729-A1 | PROPHYLACTIC AND THERAPEUTIC TREATMENT OF INFECTIOUS AND OTHER DISEASES WITH IMMUNOEFFECTOR COMPOUNDS | NFATC1, AGPS, HLA-DRB1 | TLR4 119/4885LY96 113/4885 |
| US-20030148993-A1 | Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds | NFATC1, AGPS, HLA-DRB1 | TLR4 119/4885LY96 113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.